Issued to :

Name : Mr. SUMIT Registration No. : 3120802340

Gender/Age : Male / 21 Years Registered At : Vimta Clinical Diagnostics Delhi
Referred by : Dr. Fatima Hospital Sample Drawn On : 12-Dec-2023 13:16
Client Code : UPP177 Sample Registered On : 13-Dec-2023 13:15
Client Name : Well Diagnostics,Prayagraj-UPP177 Reported On : 15-Dec-2023 12:44
Sub Client : Reported Printed On : 15-Dec-2023 12:50
Sample Type : Li Heparin

SEROLOGY
Test Description Value Observed Unit
Quantiferon TB Gold(QFT)

TB Nil 0.28 IU/mL

TB Antigen 0.28 IU/mL
TB Antigen- Nil <0.01 IU/mL
3120802340-Mr. SUMIT-21 Years-Male

Results Negative
Method : ELISA

Page 1 of 2
DR.MADHAVI LATHA
MC-2327 MD - MICROBIOLOGY

Processing Lab : Vimta Labs Limited,Cherlapally

Address: Vimta labs Limited Plot no :142, IDA, Phase ll, Cherlapally, Hyderabad-500051. Ph: 040-67404040 Extn: 7171/7272
 Issued to :
Name : Mr. SUMIT Registration No. : 3120802340
Gender/Age : Male / 21 Years Registered At : Vimta Clinical Diagnostics Delhi
Referred by : Dr. Fatima Hospital Sample Drawn On : 12-Dec-2023 13:16
Client Code : UPP177 Sample Registered On : 13-Dec-2023 13:15
Client Name : Well Diagnostics,Prayagraj-UPP177 Reported On : 15-Dec-2023 12:44
Sub Client : Reported Printed On : 15-Dec-2023 12:50
Sample Type : Li Heparin

Interpretation:
Nil (IU/mL) TB Antigen minus Nil (IU/mL) QFT Result Report/ Interpretation
<=8.0 <0.35 Negative M. tuberculosis infection not likely
<=8.0 >=0.35 and <25% of Nil value Negative M. tuberculosis infection not likely
<=8.0 >=0.35 and >=25% of Nil value Positive M. tuberculosis infection likely
>8.0 Any Indeterminate Results are indeterminate for Antigen responsiveness

• Diagnosing or excluding tuberculosis disease, and assessing the probability of LTBI, requires a combination of
epidemiological, historical, medical, and diagnostic findings that should be taken into account when interpreting QFT
3120802340-Mr. SUMIT-21 Years-Male

results.
• The magnitude of the measured IFN-gamma level cannot be correlated to stage or degree of infection, level of
responsiveness, or likelihood for progression to activedisease.
• Results from QFT testing must be used in conjunction with each individual epidemological history, current medical
status, and other diagnostics evaluations.
• Individuals with Nil vales greater than 8 IU/mL are classed as indeterminate because a 25% higher response to the TB
Antigen may be outside the assay measurement ranges
• Unreliable or indeterminate results may occur due to, excessive levels of circulating gamma interferon or presence of
heterophile antibodies.
• This test cannot differentiate between latent infection and active tuberculosis.

------------------ End Of Report ------------------

Note: Assay results should be interpreted only in the context of other laboratory findings and the total clinical status of the patient.For test performed on specimens
received or collected from non-VLL locations,it is presumed that the specimen belongs to the patient named or identified as labeled on the container/test request and
such verification has been carried out at the point generation of the said specimen by the sender.
Test Marked with # are referred to our accredited Partner Lab.

Page 2 of 2
DR.MADHAVI LATHA
MC-2327 MD - MICROBIOLOGY

Processing Lab : Vimta Labs Limited,Cherlapally

Address: Vimta labs Limited Plot no :142, IDA, Phase ll, Cherlapally, Hyderabad-500051. Ph: 040-67404040 Extn: 7171/7272
 Clinical Reference Laboratory
Terms and conditions governing this test report

1. The reported results are for information and interpretation of the referring doctor or such other medical
Professionals, who understand reporting units, reference ranges and limitations of technologies. VIMTA will
not be responsible for any interpretation whatsoever.
2. It is presumed that the test(s) performed are, on the specimen(s)/sample(s) belonging to the patient named
or identified and the verifications of the particulars have been carried out by the patient or his/her
representative at the point of generation of said specimen. The reported results are restricted to the given
Specimen(s) only.
3. Results may vary from lab to lab and from time to time for the same parameter for the same patient. Assays
are performed in accordance with standard procedures. The reported results are dependent on individual
assay methods/equipments used and quality of specimen(s) received.
4. If the result(s) of the test(s) is alarming or unexpected, the patient is advised to contact the laboratory
immediately for possible further action/suggestion.
5. A microbiological "Preliminary Report" indicates that results are primary and/or yet to be reported for one or
more of the tests, or else, as is the case with many microbiology tests, a "Final" culture, identification or drug
susceptibility result might be pending. In such cases, "Preliminary Report" header will be replaced by "Final
Report" and the preliminary results will be superseded by final results.
6. This report is not valid for medico legal purposes.
7. VIMTA expressly rejects any & all claims of any nature whatsoever, where soever arising from or relating to
the performance of the requested tests as well as any claim for indirect, incidental or consequential damages.
The total liability, scientifically and legally proven, if any, of VIMTA LABS LTD., in any case, shall not exceed
the invoiced amount for the services provided and paid for.
8. The test report shall not be reproduced either in part or full without the written approval of VIMTA.

CENTRAL REFERENCE LABORATORY & REGIONAL REFERENCE LABORATORIES

REG. OFFICE
Vimta Labs Ltd., 142, IDA Phase II, Cherlapally,
Hyderabad - 500 051. T: +914027264141.
For queries: helpline@vimta.com,
Complaints: quality@vimta.com
LIFE SCIENCES CAMPUS
# 5, MN Park , Genome Valley, Shamirpet, Medchal -
Malkajgiri District. Hyderabad - 500 101.
+91 40 67404040. URL: www.vimta.com
New Delhi: Vimta Labs Ltd., 61/2, Manmohan Building,
Yusuf Sarai, Green park Market, Hauz Khas,
New Delhi - 110016., +91 7995333503 & 7995333504,
Crldelhi.lab@vimta.in
Kolkata: 1st Floor, EN-34, Salt Lake , Sector- 5,
Kolkata - 700 091. +91 7995333500 & 7995333501.
kol.lab@vimta.com

BRANCH LABORATORIES
Vijayawada: D. No. 29-5-1, Shyam Enclave,
Cherukupallivari Street., Opp. Glaxo, Prakasam Road,
Governorpet, Vijayawada - 520 002. 08662438122,
vimtavj@vimta.com
Visakhapatnam: No. 15-13-2A, Ground Floor, Krishna
Nagar, Maharanipeta, Visakhapatnam - 530 002.
0891-6670394, vimtavs@vimta.com
Tirupati: Door No:6-2-91, Amrutha Plaza, Old Maternity
Hospital Road, Opposite S V Balamandir School,
Tirupati- 517501. 0877-2221777, vimta.tir@vimta.com
Hyderabad: Vimta Swasa Clinical Diagnostics
Swasa Hospitals (India) Pvt. Ltd.
Beside Narayanguda Flyover, Next to Taj Mahal Hotel,
Narayanguda, Hyderabad, Telangana 500029
9676760000, vimta.swasa@vimta.com
Hyderabad: Vimta Swasa Clinical Diagnostics
Building no. #50, 3rd Floor, Kavuri Hills Road,
Opp Metro Pillar-1710, CBI Colony, Madhapur,
Hyderabad-500081
9676760000, vimta.madhapur@vimta.com
Chennai: No.33, Ganga Nagar, Jafferkhanpet,
Chennai - 600 083. 9042057890,
vimtamas@vimta.com
Prayagraj: Vimta Kriti Clinical Diagnostics
Kriti Scanning Centre (P) Ltd.
59/18E, Lowther Road, Prayagraj, Uttar Pradesh 211002.
0532-2256805, 2256266
vimta.prayagraj@vimta.com
Varanasi: No. B-31/82, 2nd Floor, Rashmi Nagar,
Near BHU Emergency Gate, Naria Road,
Varanasi - 221 005, 9121293542,
vimtavns@vimta.com
Bhubaneswar: House No. 16 C, BDA, HIG Duplex
Colony, Baramunda, Opp Kali Mandir,
Bhubaneswar- 751 003.
7995333517, vimtabbi@vimta.com.